NDA后药品专利的普遍性及其与仿制药批准时间的关系

IF 33.1 1区生物学 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Nature biotechnology Pub Date : 2024-09-13 DOI:10.1038/s41587-024-02371-4

Jonathan J. Darrow, Victor Van de Wiele, Beatrice Brown, Aaron S. Kesselheim

引用次数: 0

摘要

在新药申请（NDA）获得批准后提交专利申请的情况并不多见，而且在大多数情况下，专利申请似乎并不会严重推迟仿制药的审批。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

The prevalence of post-NDA drug patents and their relationship to the timing of generic approval

查看原文本刊更多论文

The prevalence of post-NDA drug patents and their relationship to the timing of generic approval

Patent applications filed after a New Drug Application (NDA) is approved are uncommon and do not appear to substantially delay approval of generic drugs in most cases.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature biotechnology 工程技术-生物工程与应用微生物

CiteScore

63.00

自引率

1.70%

发文量

382

审稿时长

3 months

期刊介绍： Nature Biotechnology is a monthly journal that focuses on the science and business of biotechnology. It covers a wide range of topics including technology/methodology advancements in the biological, biomedical, agricultural, and environmental sciences. The journal also explores the commercial, political, ethical, legal, and societal aspects of this research. The journal serves researchers by providing peer-reviewed research papers in the field of biotechnology. It also serves the business community by delivering news about research developments. This approach ensures that both the scientific and business communities are well-informed and able to stay up-to-date on the latest advancements and opportunities in the field. Some key areas of interest in which the journal actively seeks research papers include molecular engineering of nucleic acids and proteins, molecular therapy, large-scale biology, computational biology, regenerative medicine, imaging technology, analytical biotechnology, applied immunology, food and agricultural biotechnology, and environmental biotechnology. In summary, Nature Biotechnology is a comprehensive journal that covers both the scientific and business aspects of biotechnology. It strives to provide researchers with valuable research papers and news while also delivering important scientific advancements to the business community.